12
APP23
APP
Transgene containing human APP (isoform 751) containing the Swedish (KM670/671NL) mutation under the murine Thy1 promoter.
13
This animal is a cross between a PSEN1 knock-in line and an APP over-expressing l
ine. The PS1 knock-in line was generated by introducing two point mutations in the wild-type mouse APP751SL/PS1 APP, PSEN1, corresponding to the mutations M233T and L235P. PSEN1 KI APP751SL overexpresses human APP751 carrying the London (V717I) and Swedish (K670N/M671L) mutations under the control of the Thy1 promoter. Transgene consisting of the signal plus 99-amino acid carboxylterminal sequence (SbC) of APP under the control of a cytomegalovirus enhancer/β-actin promoter.
14
APP-C99 (tg13592)
APP
15
APPDutch
APP
Transgenic mice with human APP751 bearing the E693Q mutation under the murine Thy1 promoter.
16
APP Knock-In APP
Knock-in of wild-type mouse APP exon 16 (truncated after residue KM), FLAG tag (2 repeats), a stop codon, a poly A signal region from the human growth hormone gene and an additional copy of exon 16 carrying the Swedish mutation and a modified exon 17 with the London and Dutch mutations. Inactivation of the mouse APP gene by replacing a 3.8 kb sequence encoding the promoter and exon 1 with a neomycin resistance cassette. Knock-in of APP sequence including introns 15 to 17. Sequence was modified to contain a humanized Aβ region and the Swedish and Beyreuther/Iberian mutations.
17
APP Knockout
APP
18
APP NL-F
APP
19
APP NL-G-F
APP
Knock-in of APP sequence including introns 15 to 17. Sequence was modified to contain a humanized Aβ region and three pathogenic mutations (Swedish, Beyreuther/Iberian, and Arctic).
20
APPPS1
Human transgenes APP KM670/671NL and PSEN1 L166P, both APP, under the control of the Thy1 promoter. Integration site is on PSEN1 lower arm of chromosome 2 between 40 and 60 cm.
21
APPsw/0; Pdgfrβ +/-
APP, PDGF RB
Progeny of APPsw transgenics (Tg2576) crossed with pericytedeficient mice. Tg2576 express human APP with the Swedish double mutation driven by the hamster prion promoter. Pericytedeficient mice were made by disrupting the Pdgfrβ gene using a PGKneobpA expression cassette to replace a 1.8 kb genomic segment spanning the signal peptide to the second immunoglobulin domain of PDGFRβ.

Regimen Summary of Peptide Medicines for Alzheimer’ Disease (AD) Treatment ---Summarized peptide regimen for in vivo AD study Animal Study Model 3xTg-AD...
第二节 阿尔茨海默病(Alzheimer's disease,AD)阿尔茨海默病(Alzheimer's disease,AD) ,是发生于老年和老年前期、以 进行性认知功能障碍和行为损害为特征的中枢...
Medicines for Alzheimer’ Disease (AD) Treatment ---Summarized peptide regimen for in vivo AD study Animal Study Model 3xTg-AD Transgenic Mice Medicine ?...
阿尔茨海默病(Alzheimer’SDisease,AD)与动力相关蛋白1(dynamin—relatedprotein1,Drp1)_基础医学_医药卫生_专业资料。第3 0卷第 2期 201 3年 4月 生物学...
让我们向江教练致敬,并祝老年痴呆症患者早日康复! 治疗老年痴呆症的小偏方所谓的老年痴呆症,又称阿尔茨海默病(alzheimer's disease,ad)是发生在老年期及老年前期...
b.老年痴呆病 老年性痴呆病,分为阿尔茨海默病(Alzheimer’sdisease,AD)和血管性痴呆(VD) ,是一 种发病于老年期前后的原发性大脑退行性疾病。 近年来老年性痴呆...
老年痴呆症的护理 老年痴呆症又称阿尔茨海默病 (Alzheimer's disease,AD) 是发生在老年期及老年前期的一种 原发性退行性脑病, 指的是一种持续性高级神经功能...
In order to study AD pathology and develop AD ...Using Tg6799 as a mouse model for AD research ...(Alzheimer’s disease,AD)又称老年痴呆症,是一...
Alzheimer's disease 老年痴呆症Alzheimer's disease 老年痴呆症隐藏>> review article Pathways towards and away from Alzheimer’s disease Mark P. Mattson ...
老年痴呆症,又称阿尔茨海默病 (Alzheimer's disease,AD) 是发生在老年期 及老年前期的一种原发性退行性脑病,指 的是一种持续性高级神经功能活动障碍, 即在没...
热门文档